Tag: offerings

GATE Academy and Unacademy partner to bring best offerings for GATE Aspirants

Leave a comment
GATE Academy and Unacademy partner to bring best offerings for GATE Aspirants

Unacademy, India’s largest learning platform, today announced its partnership with GATE Academy, a leading test prep platform for GATE exam preparation. This partnership will further strengthen GATE offerings for aspirants with the best pedagogy curated by India’s top Educators under one roof. 

The partnership with GATE Academy is one more step towards Unacademy’s vision of democratizing education and making high-quality content accessible to all. Both Gate Academy and Unacademy Learners will have access to the best quality content, teaching methodologies and immersive technology experience.

As part of this collaboration, Umesh Dhande, one of India’s leading GATE Educators has joined Unacademy as Vice President, Academics, GATE & ESE and is already enabling millions of Learners with their expert curriculum. Unacademy has also announced the first GATE combat exam post the partnership which is enabled on the Unacademy platform and curated by the GATE Academy team, which will be conducted on 25th September 2022 at 11 PM.

Aspirants who ace GATE Combat will be eligible to win scholarships and rewards of up to INR 30 Cr**. Further top rankers can also win one-year Unacademy scholarship** and the top 3000 rankers can win free GATE 2023 exam registration** and other exciting prizes**.

GATE Academy and Unacademy partner to bring best offerings for GATE Aspirants

Currently, Unacademy offers over 3800 courses in the GATE and ESE for aspirants to prepare for elective branches in Computer Science, Mechanical, Electrical, Civil, Electronics & Communication and Chemical. By enrolling for the GATE course, Learners will have access to interactive live classes, structured courses, regular mock tests, and quizzes, get detailed analysis of their performance and more.

For more details on Combat click here:

https://unacademy.com/scholarship/combat_gate_ese

Novo Holdings leads $50 million investment in MedGenome to accelerate expansion into new markets and deepen product offerings

Leave a comment
Novo Holdings leads $50 million investment in MedGenome to accelerate expansion into new markets and deepen product offerings

MedGenome, the leading genetic diagnostics, research, and data company in South Asia, announced today a $50 million investment led by Novo Holdings, an international leader in life science investing.To date, MedGenome has administered more than 300,000 complex genetic tests and served over 200,000 patients. The Company obtains samples from nearly 4,000 hospitals and 10,000 physicians across the globe. Novo’s investment will strengthen MedGenome’s scale beyond India and South Asia into Africa and the Middle East and democratize access to genetic testing and personal healthcare across emerging markets. MedGenome is a co-founding member of the GenomeAsia 100K Project and has built the largest database of South Asian genetic variants―its continued expansion will contribute to the most comprehensive genomic dataset in the world.

MedGenome genetic testing provides insights into complex, noncommunicable diseases to aid in the drug discovery and clinical trials for treatment in the areas of oncology, diabetes, ophthalmology, cardiology, and other rare diseases.

This latest round of funding will be used to broaden MedGenome’s product offering and improve the reach of its key diagnostic services, including reproductive and oncology services, as well as the enhancement of MedGenome’s bioinformatics and SaaS offerings.    

“The success that the MedGenome team has achieved over the last decade is extraordinary,” said Amit Kakar at Novo Holdings. “MedGenome’s mission to transform the future of personalized healthcare―one that is affordable, inclusive, and equitable―is a perfect fit with Novo’s investment strategy and broader portfolio.”

“The MedGenome team has built a model of accessibility across South Asia that delivers cutting-edge diagnostic tests, at the same global standard of quality as other market leaders, and at a fraction of the cost,” said Mahesh Pratapneni, Group CEO of MedGenome. “We’re thrilled to have the support of the leader in international life sciences investing behind us as we expand into new global markets and scale access to affordable and life-changing testing.”

Novo Holdings leads $50 million investment in MedGenome to accelerate expansion into new markets and deepen product offerings

“MedGenome is leading the cultural shift of healthcare, taking it from one of generalization to a model that prioritizes precision medicine,” said Dr. Felix Olale, Chairman of MedGenome’s Board of Directors, and Global Co-Lead for Healthcare Investments at LeapFrog Investments. “Breakthroughs and discovery are only as successful as the data on which they’re based, and MedGenome’s mission to expand the global genomic dataset to aid in the development of more inclusive and equitable research & drug discovery is not only inspiring, but critical to the future of global healthcare.”

The investment will give Novo Holdings a significant minority stake in MedGenome. LeapFrog Investments, which led a $55 million investment round in MedGenome in April 2020, will be adding to its investment alongside Novo, as well as existing investor, Sofina.